• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Evaluation of anti-tubercular activity of linolenic acid and conjugatedlinoleic acid as effective inhibitors against Mycobacterium tuberculosis

    2016-11-29 12:06:03WonHyungChoi

    Won Hyung Choi

    Department of Biomedical Science, and Department of Medical Zoology, Kyung Hee University School of Medicine, 26 Kyunghee-daero, Dongdaemun-gu, Seoul 130-701, Republic of Korea

    Evaluation of anti-tubercular activity of linolenic acid and conjugatedlinoleic acid as effective inhibitors against Mycobacterium tuberculosis

    Won Hyung Choi*

    Department of Biomedical Science, and Department of Medical Zoology, Kyung Hee University School of Medicine, 26 Kyunghee-daero, Dongdaemun-gu, Seoul 130-701, Republic of Korea

    ARTICLE INFO

    Article history:

    Received 15 November 2015

    Received in revised form 20 December 2015

    Accepted 15 January 2016

    Available online 20 February 2016

    MGIT 960 system

    Tuberculosis

    Drug susceptibility testing

    γ-linolenic acid

    Objective: To evaluate a new pharmacological activity/effect of linolenic acid (α- and γ-form) and conjugated-linoleic acid (CLA) causing antibacterial activity against Mycobacterium tuberculosis (Mtb). Methods: The anti-Mtb activity/effect of linolenic acid and CLA were determined using different anti-Mtb indicator methods such as resazurin microtiter assay (REMA) and MGIT 960 system assay. The Mtb was incubated with various concentrations (12.5-200) μg/mL of the compounds and anti-Mtb first-line drugs for 5 d in the REMA, and for 3 wk in MGIT 960 system assay. Results: Linolenic acid and CLA obviously indicated their anti-Mtb activity/effect by strongly inhibiting the growth/proliferation of Mtb in a dosedependent manner in the REMA and the MGIT 960 system assay. Interestingly, linolenic acid and CLA consistently induced anti-Mtb activity/effect by effectively inhibiting the growth/ proliferation of Mtb in MGIT 960 system for 21 d with a single-treatment, and their minimum inhibitory concentrations were measured as 200 μg/mL respectively. Conclusions: These results demonstrate that linolenic acid and CLA not only have effective anti-Mtb activity/ properties, but also induce the selective-anti-Mtb effects by strongly inhibiting and blocking the growth/proliferation of Mtb through a new pharmacological activity/action. Therefore, this study provides novel perspectives for the effective use of them and the potential that can be used as potent anti-Mtb candidate drugs, as well as suggests the advantage of reducing the cost and/or time for developing a new/substantive drug by effectively repurposing the existing drugs or compounds as one of new strategies for the global challenge of tuberculosis.

    1. Introduction

    The rapid emergence of tuberculosis (TB) is still causing a serious global challenge and difficulty including drug-resistant TB despite various global efforts such as hygiene education, environment improvement, and drug development. Mycobacterium tuberculosis (Mtb) is a major infectious factor causing the highest human mortality through the co-infection with HIV/AIDS as one of the most dangerous infectious bacteria globally. In 2013, 9.0 millionpeople were estimated as new TB, 1.5 million died from the disease, and 360 000 of them were HIV-positive. In addition, 1.1 million of the 9 million people diagnosed as new TB cases in 2013 were HIV-positive. Recently, TB cases co-infected with HIV/AIDS indicated the highest infectious rate in the African region compared with the other countries, particularly, in southern Africa. Furthermore, most of the estimated TB cases in 2013 occurred in Asia (56%) and the African region (29%), and the three countries of the largest number of TB cases were India (2.0 million-2.3 million), China (0.9 million-1.1 million), and Nigeria (340 000-880 000)[1,2]. For these reasons, various studies for the treatment and/or the inhibition of TB that induces drug-resistance to existing agents have been carried out in the drug discovery field worldwide. Although various anti-TB drugs (from first-line drugs to third-line drugs) were developed for the treatment of TB-patients, they have showed the limit in reducing thecurrent TB patients. Recently, compounds such as PA 824, SQ 109, bedaquiline, and linezolid repurposed through chemical remodeling of the existing drugs as well as new compounds such as Q203, TMC 207, pyridomycin, and thiophenes are being tested in Phase I or Phase III trials as novel anti-TB drugs[1,3-7]. Until recently, in spite of the discovery of new targets and/or drugs for treating TB, the rapid emergence of TB, and multidrug-resistant TB (MDR-TB) or extensively drug-resistant TB has still caused serious concerns in the public health field worldwide. For these reasons, various studies for developing the effective anti-TB drugs with novel mechanisms of action, low cytotoxicity and safety are urgently needed to block and/or to inhibit the TB. In this aspect, this study was carried out to evaluate anti-Mtb activity/effect/ability of linolenic acid (α- and γ-form) and conjugated-linoleic acid (CLA) that effectively act as bioactive substance, and to identify the potential for developing them as novel anti-tubercular drugs.

    2. Materials and methods

    2.1. Materials

    Various materials used in this study, rifampicin, isoniazid, linolenic acid (α-and γ-form), CLA [conjugated(9Z,11E)-linoleic acid, conjugated(9E,11E)-linoleic acid, and conjugated(10E,12Z)-linoleic acid], resazurin powder and DMSO, were purchased from Sigma-Aldrich Chemical, Co., Ltd. (St, Louis, MO, USA), and MGITTM960 system indicator 7mL grwoth media tubes with BACTEC?MGIT? 960 supplement kit were purchased from Becton-Dickinson and Company (Sparks, MD, USA). All other chemicals and reagents were purchased from Merck Chemical Co., Ltd. (Darmstadt, Germany) and Sigma-Aldrich Chemical Co., Ltd. (St. Louis, MO, USA).

    2.2. Preparation of anti-Mtb drugs

    The anti-Mtb first-line drug, isoniazid, was dissolved in sterile distilled water, and rifampicin was dissolved in DMSO, to a concentration of 50 mg/mL according to the manufacturer’s instruction. The anti-Mtb first-line drugs were used as reference standard drugs. All compounds were filtered using 0.2 μm membrane syringe filter (Roshi Kaisha, Ltd., Tokyo, Japan) before use and stored at -80 ℃ deep-freezer until use.

    2.3. Preparation and growth conditions of Mtb

    Mtb H37RV(ATCC 27294) used in this study was purchased from American Type Culture Collection (Manassas, VA, USA). Mtb H37RVwas grown in Middlebrook 7H9 broth (Difco Laboratories, Detroit, MI, USA) supplemented with 10% (V/V) oleic acid/ albumin/dextrose/catalase enrichment (Becton-Dickinson and Company, Sparks, MD, USA) and 0.05%(v/v) Tween 80 (Sigma-Aldrich Chemical, St, Louis, MO, USA) to the log phase at 37 ℃ for 4-5 wk on shaking incubation of 100 rpm.

    2.4. Drug susceptibility testing of Mtb

    The in vitro anti-Mtb activity of linolenic acid (α- and γ-form) and CLA [conjugated(9Z,11E)-linoleic acid, conjugated(9E,11E)-linoleic acid, and conjugated(10E,12Z)-linoleic acid] against Mtb was confirmed by resazurin microtiter assay (REMA) using a 96-well micro-plate. Briefly, Mtb was grown in fresh Middlebrook 7H9 broth supplemented with 10% (v/v) oleic acid/albumin/dextrose/ catalase enrichment and 0.05% (v/v) Tween 80 until the culture reached a turbidity equal to that of 1.0 McFarland standard (3.0 × 108CFU/mL) at 37 ℃. The bacteria were adjusted to a density of 2 × 106CFU/mL in fresh culture broth. Finally, the bacterial suspensions were inoculated into all wells of a 96 well microtiter plate containing final concentrations (12.5-200) μg/mL of linolenic acid (α- and γ-form), CLA [conjugated(9Z,11E)-linoleic acid, conjugated(9E,11E)-linoleic acid, and conjugated(10E,12Z)-linoleic acid] and anti-TB first-line drugs (1.25-5) μg/mL, and Mtb growth controls containing no anti-Mtb first-line drugs and blank controls without inoculation were also included. The 96 well-plates, covered with lids, placed in a plastic bag, were incubated at 37 ℃ for 5 d. After incubation, 20 μL of freshly prepared 0.05% (w/v) resazurin solution was added to all wells of a 96 well microtiter plate, and the plates were re-incubated at 37 ℃ for 36 h. A change in color from blue to pink indicating bacterial growth was observed after 36 h of incubation. The minimum inhibitory concentration (MIC) was expressed as the lowest concentration of the drug that inhibited Mtb growth or prevented change in color of the resazurin from blue to pink based on a REMA.

    2.5. Evaluation of drug susceptibility of Mtb by MGIT 960 system assay

    To evaluate anti-Mtb effects of linolenic acid (α- and γ-form) and CLA [conjugated(9Z,11E)-linoleic acid, conjugated(9E,11E)-linoleic acid, and conjugated(10E,12Z)-linoleic acid] against the growth/ proliferation of Mtb, the drug susceptibility testing of the strain was performed using the BACTECTMMGIT 960 system (Becton Dickinson and Company, Sparks, MD. USA.). In brief, 100 μL of a suspension of Mtb culture, adjusted to 9.6 × 106CFU/mL, was inoculated in an MGIT growth media tube with BACTECTMMGIT 960 growth supplement (Becton Dickinson and Company), which were incubated with different concentrations (12.5-200) μg/mL of the tested compounds and anti-Mtb first-line drugs (10 μg/mL), and Mtb growth controls containing no anti-Mtb first-line drugs were also included. They were incubated into the BACTECTMMGIT 960 system device for 3 wk for determination of Mtb drug susceptibility.

    2.6. Statistical analysis

    All results were expressed as mean ± standard deviation of three independent experiments. Statistical analysis of the data was performed using the Student's t-test and one-way analysis of variance.

    3. Results

    3.1. Evaluation of anti-Mtb activity of the compounds against Mtb

    The anti-Mtb activity of linolenic acid (α- and γ-form) and CLA [conjugated(9Z,11E)-linoleic acid, conjugated(9E,11E)-linoleic acid, and conjugated(10E,12Z)-linoleic acid] were evaluated using the REMA. After the bacteria were incubated with various concentrations (12.5-200) μg/mL of the compounds and anti-Mtb first-line drugs (rifampicin and isoniazid) for 5 d, the growth/proliferation of Mtb were markedly inhibited in a concentration-dependent manner (Table 1), and the MIC values of linolenic acid (α- and γ-form) and CLA against the viability of Mtb were determined as 75 μg/ mL and 100 μg/mL, respectively (Table 2). Furthermore, all the compounds demonstrated their Mtb-inhibitory effects as well as anti-Mtb activity through the bacterial color change observed in the REMA. In the REMA, the superiority among the compounds regarding anti-Mtb activity/effect was confirmed that linolenic acid (α- and γ-form) was more effective compared with the CLA. These results demonstrate that the compounds not only induce anti-Mtb activity by strongly inhibiting the growth/proliferation of Mtb, but also have the potential that can be developed as potent anti-Mtb agents through their new pharmacological function/action.

    3.2. Anti-Mtb effects of the compounds against the growth/ proliferation of Mtb

    The anti-Mtb effects of the compounds against Mtb were further evaluated using the MGIT 960 system assay. The bacteria were incubated with various concentrations (12.5-200) μg/mL of the compounds and anti-Mtb first-line drugs (10 μg/mL) in an MGIT growth media tube of the BACTECTMMGIT 960 system device for drug susceptibility testing for 3 wk, and their growth units were markedly inhibited in a concentration-dependent manner. Particularly, when Mtb was incubated with 100 μg/mL of the CLA, their growth units were detected at about 8.3 d, whereas 100 μg/mL of linolenic acid (α- and γ-form) strongly inhibited the growth/ proliferation of Mtb compared with the CLA, and the growth unit of Mtb was detected at 9.3 and 10.3 d, respectively (Figure 1).Furthermore, when Mtb was incubated with all the tested compounds (200 μg/mL), their growth units were not detected at 21 d. In this MGIT 960 system assay, linolenic acid (α- and γ-form) and CLA effectively inhibited the growth/proliferation of Mtb for 3 wk with a single treatment, which showed clearly that these compounds induced similar inhibitory effects against the growth/proliferation of Mtb. These results demonstrate that the compounds induce anti-Mtb activity/effect causing the inactivation of Mtb by effectively blocking or consistently inhibiting the growth/proliferation of Mtb, as well as have unique anti-mycobacterial properties that induce anti-Mtb activity in a concentration-dependent manner.

    Table 1Anti-Mtb activity of linolenic acid (α- andγ-form) and CLA against Mtb growth/proliferation determined by the REMA assay.

    Table 2MICs of linolenic acid (α- and γ-form) and CLA against the growth/proliferation of Mtb determined by different anti-Mtb assays.

    Figure 1. Anti-Mtb activity/effect of linolenic acid (α-and γ-form) and CLA measured using the MGIT 960 system assay.

    4. Discussion

    The recent infectious pathogens have enhanced their infectivity and viability through genetic mutation or adaptability to environmental variation, which affects the treatment or prevention of the disease as well as the novel drug discovery and development. Recently serious infectious diseases such as MERS, SARS, Influenza and Ebola have been occurred in various countries worldwide, particularly, in Asia, Middle East and Africa. These diseases have typically caused more serious risk to young children whose immune function is low and the elderly who have other underlying diseases compared with normal adults. In these aspects, TB is a contagious/infectious disease to cause infection through droplets, which has caused comparatively high prevalence and mortality rates worldwide. In addition, TB is the most dangerous factor among various infectious diseases, which accounted for the second leading cause of death among infectious diseases of the world’s population in 2013 and 2014[1,2]. In particular, the increase of HIV-co infection and the rapid appearance of MDR-TB strains strongly suggest an urgent need to develop effective/safe drugs for consistently treating TB as well as induce serious concerns regarding drug-resistance in the public health fields. Recently, in spite of various efforts to discover new anti-Mtb drugs, the development for effective/safe anti-TB drugs has been still faced with a global difficulty, including the cost & time and the indifference of global pharmaceutical companies. Until recently, novel antibiotics derived from diverse biological resources and synthetic compounds have been developed to treat infectious diseases or to inhibit pathogenic microorganisms. However, the overuse of antibiotics and anti-bacterial drugs has rapidly increased the incidence of multi-drug resistant bacteria, so that many medical doctors compared with the past were confronted with more difficulty to treat patients with serious bacterial infections such as MDR-TB and extensively drug-resistant TB. In addition, the current anti-TB drugs have been causing serious side effects such as hepatotoxicity, ototoxictiy, and nephrotoxicity. For these reasons, as one of feasible solutions for overcoming limitations of the drug’s side effects, a number of researches regarding anti-Mtb drugs were reported from active substances derived from diverse medicinal plants and biological resources, and some of natural products have been studied or developed as potent candidate substances for treating TB[8-12]. However, despite various efforts for developing novel anti-TB drugs, effective/safe next generation anti-Mtb agents that can be used as a potential anti-TB drug, the extracts, natural products, semi-synthetic compounds and/or biomedicine, have not yet been reported or released in pharmaceutical market. Recently, innovative and creative alternatives for developing effective/safe drugs through substantive solutions between scientists and pharmaceuticals are being required globally.

    In this aspect, the new pharmacological activity/effect of existing drugs/compounds used for treating different diseases can provide the advantages of both the safety and efficacy compared with newly developed drugs, which may be used or utilized as one of effective strategies for developing novel drugs and as one of feasible alternatives for developing effective/safe next-generation drugs. Moreover, the compounds derived from the repurposing of existing drugs may increase the potential for developing new-next generation drugs as a useful resource for developing new substances in a medical field. For these reasons, this study was focused on major points for the discovery of new candidate substances as one of various strategies for developing anti-Mtb drugs, which were the minimization of side effects, the safety of drugs, and the finding of novel pharmacological activity/effect/function/action of existing drugs or known compounds. In these perspectives, CLA and linolenic acid (α- and γ-form) are being used as adjuvant for both medical use and healthcare as bioactive substances derived from various biological resources, including medicinal plants and marine resources. Recently, new pharmacological activity/effect/actions of CLA and linolenic acid (α- and γ-form) have been variously reported as follows: 1) Anti-adipogenic effect of α-linolenic acid through AMP-activated protein kinase[13], 2) γ-linolenic acid increases the therapeutic efficacy of irradiation in the treatment of gliomas[14], 3) The modulatory effects of CLA against both obesity and inflammatory bowel disease through peroxisome proliferatoractivated receptor gamma pathway[15], 4) α-linolenic acid protects the heart from myocardial fibrosis and cardiac injury in the rat[16], 5) Anti-allergic effect of α-linolenic acid in the gut of murine food allergy model[17], 6) The effect of omega-3 polyunsaturated fatty acid including α-linolenic acid in treating patients with nonalcoholic steatohepatitis[18].

    Taken together, these studies indicate substantial and significant evidence that linolenic acid (α- and γ-form) and CLA have not only various pharmacological activities/effects/actions in both ‘in vitro’ and ‘in vivo’ but also the potential that can be used as therapeutic agents. However, in spite of the pharmacological activities/effects/actions of them provided through these studies,their anti-TB activity/effects against Mtb have not yet been reported in both ‘in vitro’ and ‘in vivo’. In these aspects, this study has begun from hypothesis that linolenic acid (α- and γ-form) and CLA may effectively inhibit or interrupt and modulate the growth/proliferation of Mtb causing TB, which can improve the safety and increase or induce the minimization of the side effects that are caused by drug treatment. As mentioned above, the results of this study showed anti-tubercular activity/effect/ability of CLA and linolenic acid (α- and γ-form) by strongly inhibiting or blocking the growth/ proliferation of Mtb through their novel pharmacological activity/ properties. Particularly, anti-Mtb activity/effect of linolenic acid (α -and γ-form) were effectively demonstrated through the selective Mtb susceptibility-indicator assays such as the REMA and MGIT 960 system assay. All the tested compounds consistently indicated anti-Mtb activity/effect by strongly inhibiting or blocking the growth/proliferation of Mtb for 21 d with a single treatment (200 μg/mL) in MGIT 960 system assay. In addition, the differences in anti-Mtb activity/effect of them were obviously confirmed in the MGIT 960 system assay and the REMA assay; Linolenic acid (γ -form) more effectively inhibited the growth/proliferation of Mtb compared with those of linolenic acid (α-form) and CLA. The important aspect that can be considered at this point is that all the tested compounds are unsaturated fatty acid. This suggests that when the compounds are bound with Mtb in the growth stages of Mtb, chemical-binding effects between the compound and the bacteria can be increased owing to its chemical properties such as chemical affinity, absorbability, melting point, and liposolubility. Furthermore, it implies that the biochemical reactions and/or functions of the cell wall of Mtb may be blocked or inhibited by the binding of the compounds, and suggests that a cascading intracellular signalingpathway of replication as well as cell cycle-key proteins in cytoplasm may be deactivated by the compound at check points that accelerate the growth/proliferation of Mtb.

    In summary, linolenic acid (α- and γ-form) and CLA strongly inhibited the growth/proliferation of Mtb that can induce TB in those with weakened immune systems through their novel pharmacological activity/effect/function, and their anti-Mtb activity/effect and action were demonstrated through different anti-Mtb indicator assays such as the MGIT 960 system assay and the REMA. In particular, linolenic acid (γ-form) more effectively inhibited the growth/ proliferation of Mtb compared with other compounds used in this study. These results showed not only the potential for the effective use of linolenic acid (α- and γ-form) and CLA as one of feasible solutions for inhibiting or blocking TB that causes a serious threat in public health fields, but also a new pharmacological function/action concerning anti-Mtb activity/effect of them against Mtb. Therefore, this study provides significant results that linolenic acid (α- and γ-form) and CLA can be effectively used or utilized as potent candidate drugs for developing new anti-Mtb drugs of the effective/ safe next-generation in the near future. In addition, this study suggests that the compounds have the potential which may decrease the cost and/or time in clinical trials through their repurposing.

    Conflict of interest statement

    The author declares that there is conflict of interest.

    [1] World Health Organization. Global tuberculosis report 2013. Geneva: World Health Organization Press; 2013.

    [2] World Health Organization. Global tuberculosis report 2014. Geneva: World Health Organization Press; 2014.

    [3] Koul A, Arnoult E, Lounis N, Guillemont J, Andries K. The challenge of new drug discovery for tuberculosis. Nature 2011; 469(7331): 483-490.

    [4] Hartkoorn RC, Sala C, Neres J, Pojer F, Magnet S, Mukherjee R, et al. Towards a new tuberculosis drug: pyridomycin - nature's isoniazid. EMBO Mol Med 2012; 4(10): 1032-1042.

    [5] Lee M, Lee J, Carroll MW, Choi H, Min S, Song T, et al. Linezolid for treatment of chronic extensively drug-resistant tuberculosis. N Engl J Med 2012; 367(16): 1508-1518.

    [6] Pethe K, Bifani P, Jang J, Kang S, Park S, Ahn S, et al. Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis. Nat Med 2013; 19(9): 1157-1160.

    [7] Wilson R, Kumar P, Parashar V, Vilchèze C, Veyron-Churlet R, Freundlich JS, et al. Antituberculosis thiophenes define a requirement for Pks13 in mycolic acid biosynthesis. Nat Chem Biol 2013; 9(8): 499-506.

    [8] Copp BR, Pearce AN. Natural products growth inhibitors of Mycobacterium tuberculosis. Nat Prod Rep 2007; 24(2): 278-297.

    [9] Tandon R, Ponnan P, Aggarwal N, Pathak R, Baghel AS, Gupta G, et al. Characterization of 7-amino-4-methylcoumarin as an effective antitubercular agent: structure-activity relationships. J Antimicrob Chemother 2011; 66(11): 2543-2555.

    [10] Saikia D, Parveen S, Gupta VK, Luqman S. Anti-tuberculosis activity of Indian grass KHUS (Vetiveria zizanioides L. Nash). Complement Ther Med 2012; 20(6): 434-436.

    [11] Gemechu A, Giday M, Worku A, Ameni G. In vitro anti-mycobacterial activity of selected medicinal plants against Mycobacterium tuberculosis and Mycobacterium bovis strains. BMC Complement Altern Med 2013; 13: 291; DOI: 10.1186/1472-6882-13-291.

    [12] Leitao F, Leitao SG, de Almeida MZ, Cantos J, Coelho T, da Silva PE. Medicinal plants from open-air markets in the State of Rio de Janeiro, Brazil as a potential source of new antimycobacterial agents. J Ethnopharmacol 2013; 149(2): 513-521.

    [13] Zhou X, Wu W, Chen J, Wang X, Wang Y. AMP-activated protein kinase is required for the anti-adipogenic effects of alpha-linolenic acid. Nutr Metab (Lond) 2015; 12(1): 10; DOI: 10.1186/s12986-015-0006-5.

    [14] Antal O, Peter M, Hackler L Jr, Man I, Szebeni G, Ayaydin F, et al. Lipidomic analysis reveals a radiosensitizing role of gamma-linolenic acid in glioma cells. Biochim Biophys Acta 2015; 1851(9): 1271-1282.

    [15] Yuan G, Chen X, Li D. Modulation of peroxisome proliferator-activated receptor gamma (PPAR γ) by conjugated fatty acid in obesity and inflammatory bowel disease. J Agric Food Chem 2015; 63(7): 1883-1895.

    [16] Folino A, Sprio AE, Di Scipio F, Berta GN, Rastaldo R. Alpha-linolenic acid protects against cardiac injury and remodelling induced by betaadrenergic overstimulation. Food Funct 2015; 6(7): 2231-2239.

    [17] Kunisawa J, Arita M, Hayasaka T, Harada T, Iwamoto R, Nagasawa R, et al. Dietary ω3 fatty acid exerts anti-allergic effect through the conversion to 17, 18-epoxyeicosatetraenoic acid in the gut. Sci Rep 2015; 5: 9750; DOI: 10.1038/srep09750.

    [18] Nogueira MA, Oliveira CP, Ferreira Alves VA, Stefano JT, Rodrigues LS, Torrinhas RS, et al. Omega-3 polyunsaturated fatty acids in treating nonalcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial. Clin Nutr 2015; DOI: 10.1016/j.clnu.2015.05.001.

    ent heading

    10.1016/j.apjtm.2016.01.021

    *Corresponding author: Won Hyung Choi, Department of Biomedical Science, and Department of Medical Zoology, Kyung Hee University School of Medicine, 26 Kyunghee-daero, Dongdaemun-gu, Seoul 130-701, Republic of Korea.

    Tel: +82-10-2071-5679

    Fax: +82-70-8269-5679

    E-mail: whchoi@khu.ac.kr

    精品久久久久久久末码| 舔av片在线| 高清日韩中文字幕在线| 色综合亚洲欧美另类图片| 热99在线观看视频| 热99在线观看视频| 久久久久久久久大av| 又大又黄又爽视频免费| 欧美日韩在线观看h| 神马国产精品三级电影在线观看| 国产免费福利视频在线观看| 日本免费在线观看一区| 全区人妻精品视频| 国产黄片美女视频| 免费无遮挡裸体视频| 国产精品1区2区在线观看.| 黄色一级大片看看| 国产精品.久久久| 欧美不卡视频在线免费观看| 国内精品一区二区在线观看| 精品少妇黑人巨大在线播放| 高清视频免费观看一区二区 | 国产精品国产三级专区第一集| 亚洲精品视频女| 亚洲精品视频女| 街头女战士在线观看网站| av播播在线观看一区| 在线观看一区二区三区| 最新中文字幕久久久久| 99久久精品热视频| 少妇丰满av| 只有这里有精品99| 国产精品福利在线免费观看| 日本色播在线视频| 最新中文字幕久久久久| 免费电影在线观看免费观看| 亚洲18禁久久av| 亚洲av成人av| 噜噜噜噜噜久久久久久91| 少妇裸体淫交视频免费看高清| 观看美女的网站| 在线观看免费高清a一片| 丰满少妇做爰视频| 能在线免费看毛片的网站| 一级毛片我不卡| 在线 av 中文字幕| 中文乱码字字幕精品一区二区三区 | 欧美xxxx黑人xx丫x性爽| 午夜老司机福利剧场| 亚洲最大成人手机在线| 精品人妻熟女av久视频| 韩国高清视频一区二区三区| 久久久久性生活片| 国产亚洲一区二区精品| 精品久久久久久成人av| 老师上课跳d突然被开到最大视频| 国产色爽女视频免费观看| 在线观看人妻少妇| 成人午夜精彩视频在线观看| 99久久精品一区二区三区| 人人妻人人看人人澡| 精品少妇黑人巨大在线播放| 三级经典国产精品| 欧美最新免费一区二区三区| 免费观看av网站的网址| 欧美日韩一区二区视频在线观看视频在线 | 舔av片在线| 日本爱情动作片www.在线观看| av在线播放精品| 狂野欧美激情性xxxx在线观看| 综合色丁香网| 97热精品久久久久久| 亚洲精品日本国产第一区| 日韩一区二区三区影片| 超碰97精品在线观看| 国产久久久一区二区三区| 熟妇人妻不卡中文字幕| 国产大屁股一区二区在线视频| 免费人成在线观看视频色| 美女被艹到高潮喷水动态| av专区在线播放| 搞女人的毛片| 伊人久久精品亚洲午夜| 国产男女超爽视频在线观看| 大话2 男鬼变身卡| 国产黄色免费在线视频| 日韩精品有码人妻一区| 日本wwww免费看| 日韩av免费高清视频| 深爱激情五月婷婷| 少妇猛男粗大的猛烈进出视频 | 插阴视频在线观看视频| av专区在线播放| 老女人水多毛片| 亚洲欧美成人精品一区二区| 看黄色毛片网站| 大香蕉久久网| 亚洲av日韩在线播放| 国产午夜精品久久久久久一区二区三区| 久久精品夜夜夜夜夜久久蜜豆| 国产伦精品一区二区三区视频9| 男女边吃奶边做爰视频| 18禁在线播放成人免费| 一区二区三区乱码不卡18| 国产黄色视频一区二区在线观看| 99热这里只有精品一区| 联通29元200g的流量卡| 十八禁网站网址无遮挡 | 久久久久久久久大av| 淫秽高清视频在线观看| av在线播放精品| 亚洲欧美中文字幕日韩二区| 久久久久性生活片| 国产 一区 欧美 日韩| 亚洲精品一二三| 国产精品一区二区在线观看99 | 舔av片在线| 欧美日韩国产mv在线观看视频 | 国产av在哪里看| 国产精品久久久久久精品电影| 一级片'在线观看视频| 在线免费观看的www视频| 日韩成人av中文字幕在线观看| 日本一二三区视频观看| 麻豆精品久久久久久蜜桃| 国产大屁股一区二区在线视频| kizo精华| av天堂中文字幕网| 国产爱豆传媒在线观看| 国产一区二区三区av在线| 国产一区二区三区av在线| 婷婷色麻豆天堂久久| 蜜臀久久99精品久久宅男| 久久久亚洲精品成人影院| 热99在线观看视频| 国产视频首页在线观看| 男女视频在线观看网站免费| 免费黄色在线免费观看| 亚洲av在线观看美女高潮| 国产精品人妻久久久久久| 精品不卡国产一区二区三区| 亚洲精品亚洲一区二区| 久久精品夜夜夜夜夜久久蜜豆| 国产黄a三级三级三级人| 91久久精品国产一区二区成人| 能在线免费观看的黄片| 亚洲国产成人一精品久久久| 国产淫语在线视频| 色综合色国产| 天天躁夜夜躁狠狠久久av| 哪个播放器可以免费观看大片| 色哟哟·www| 国产精品久久视频播放| 国产亚洲一区二区精品| 黄色欧美视频在线观看| 亚洲最大成人中文| 在线观看av片永久免费下载| 久久久成人免费电影| 在线观看美女被高潮喷水网站| 日韩亚洲欧美综合| 中文字幕免费在线视频6| 国产又色又爽无遮挡免| 欧美区成人在线视频| 国产精品综合久久久久久久免费| 日韩制服骚丝袜av| 嫩草影院精品99| 在线 av 中文字幕| 国产在线一区二区三区精| 伦精品一区二区三区| 人妻夜夜爽99麻豆av| 男人舔女人下体高潮全视频| 搡老乐熟女国产| 好男人在线观看高清免费视频| 别揉我奶头 嗯啊视频| 亚洲精品一二三| 亚洲精品aⅴ在线观看| 久久久久精品久久久久真实原创| 精品一区在线观看国产| 精品久久久精品久久久| 免费看日本二区| 日韩欧美一区视频在线观看 | 搡女人真爽免费视频火全软件| 观看美女的网站| 秋霞在线观看毛片| 国产精品麻豆人妻色哟哟久久 | 成人午夜高清在线视频| 97热精品久久久久久| 99久国产av精品| 亚洲国产日韩欧美精品在线观看| 大话2 男鬼变身卡| av免费在线看不卡| 一二三四中文在线观看免费高清| 秋霞在线观看毛片| 久久精品熟女亚洲av麻豆精品 | 日韩大片免费观看网站| 校园人妻丝袜中文字幕| 最近的中文字幕免费完整| 免费少妇av软件| 国产av码专区亚洲av| 天天一区二区日本电影三级| 纵有疾风起免费观看全集完整版 | 2021少妇久久久久久久久久久| 丝瓜视频免费看黄片| 人人妻人人看人人澡| 纵有疾风起免费观看全集完整版 | 春色校园在线视频观看| 蜜桃亚洲精品一区二区三区| 少妇的逼水好多| 人人妻人人澡欧美一区二区| 国产成人精品婷婷| 午夜老司机福利剧场| 国产精品蜜桃在线观看| 久久亚洲国产成人精品v| 亚洲精品视频女| 麻豆国产97在线/欧美| 亚洲最大成人手机在线| 老师上课跳d突然被开到最大视频| h日本视频在线播放| 亚洲熟女精品中文字幕| 青春草亚洲视频在线观看| 亚洲国产精品成人久久小说| 一级爰片在线观看| 国产高清不卡午夜福利| 亚洲怡红院男人天堂| 男女视频在线观看网站免费| 欧美极品一区二区三区四区| 亚洲在久久综合| av在线观看视频网站免费| 夫妻午夜视频| 国产黄色视频一区二区在线观看| 国产淫语在线视频| 大陆偷拍与自拍| www.色视频.com| 国产免费视频播放在线视频 | 欧美日韩精品成人综合77777| 观看美女的网站| 亚洲成人一二三区av| 日韩在线高清观看一区二区三区| av网站免费在线观看视频 | 国产精品嫩草影院av在线观看| 日本一本二区三区精品| 欧美三级亚洲精品| 亚洲av男天堂| 亚洲va在线va天堂va国产| 亚洲精品一区蜜桃| 亚洲经典国产精华液单| 亚洲国产av新网站| 少妇猛男粗大的猛烈进出视频 | 国产免费又黄又爽又色| 欧美三级亚洲精品| 国产精品人妻久久久影院| 成人无遮挡网站| 高清在线视频一区二区三区| h日本视频在线播放| 草草在线视频免费看| 少妇猛男粗大的猛烈进出视频 | 成人一区二区视频在线观看| 精品一区二区三区人妻视频| 久久久国产一区二区| 久99久视频精品免费| 免费人成在线观看视频色| 国产永久视频网站| 久久久久久国产a免费观看| 最近的中文字幕免费完整| 国产成人午夜福利电影在线观看| 成人毛片a级毛片在线播放| 精品久久久久久久久av| 简卡轻食公司| 欧美潮喷喷水| 亚洲精品乱码久久久久久按摩| 亚洲精品国产成人久久av| 一级黄片播放器| 国产又色又爽无遮挡免| 国产三级在线视频| 嫩草影院新地址| 天堂俺去俺来也www色官网 | 久久久久精品久久久久真实原创| 性插视频无遮挡在线免费观看| 日日啪夜夜爽| 欧美三级亚洲精品| 国产成人福利小说| 能在线免费观看的黄片| 亚洲欧美成人精品一区二区| 日韩欧美精品v在线| 啦啦啦中文免费视频观看日本| 亚洲久久久久久中文字幕| 夫妻性生交免费视频一级片| 少妇被粗大猛烈的视频| 毛片一级片免费看久久久久| 高清毛片免费看| 亚洲成色77777| 国产成人免费观看mmmm| 好男人在线观看高清免费视频| 80岁老熟妇乱子伦牲交| 男女边摸边吃奶| 深爱激情五月婷婷| 亚洲av电影不卡..在线观看| 老司机影院毛片| 国产精品国产三级国产av玫瑰| 嫩草影院入口| 老师上课跳d突然被开到最大视频| 永久网站在线| av一本久久久久| 免费看日本二区| 国产精品1区2区在线观看.| 爱豆传媒免费全集在线观看| 在线 av 中文字幕| 国产成人午夜福利电影在线观看| 精品人妻视频免费看| 欧美成人a在线观看| 久久久久久久亚洲中文字幕| 国产高潮美女av| 欧美一区二区亚洲| 熟妇人妻不卡中文字幕| 亚洲第一区二区三区不卡| 久久久精品94久久精品| 99久国产av精品| 久久久久久久久久人人人人人人| 亚洲熟妇中文字幕五十中出| 99热全是精品| 中文字幕久久专区| 九九在线视频观看精品| 亚洲国产欧美在线一区| 国产精品美女特级片免费视频播放器| 欧美+日韩+精品| 日韩伦理黄色片| 欧美日韩国产mv在线观看视频 | 69人妻影院| 日韩欧美国产在线观看| 国产精品一区二区性色av| 我要看日韩黄色一级片| 国产91av在线免费观看| 亚洲电影在线观看av| 国产国拍精品亚洲av在线观看| 国产视频内射| 天天一区二区日本电影三级| 国产 亚洲一区二区三区 | 99久国产av精品国产电影| 国产精品人妻久久久久久| 26uuu在线亚洲综合色| 欧美xxxx黑人xx丫x性爽| 欧美潮喷喷水| 91av网一区二区| 亚洲va在线va天堂va国产| 小蜜桃在线观看免费完整版高清| 少妇被粗大猛烈的视频| 老司机影院成人| 特级一级黄色大片| 97超视频在线观看视频| 99热6这里只有精品| 亚洲av二区三区四区| 男女边吃奶边做爰视频| 亚洲精品国产av蜜桃| 大话2 男鬼变身卡| 视频中文字幕在线观看| 久久久a久久爽久久v久久| 免费高清在线观看视频在线观看| 精品久久久久久久末码| 成人午夜精彩视频在线观看| 久久久久精品久久久久真实原创| 亚洲国产精品成人久久小说| 成人高潮视频无遮挡免费网站| xxx大片免费视频| 国产一级毛片在线| 寂寞人妻少妇视频99o| 国产精品精品国产色婷婷| 日日啪夜夜爽| 国产精品国产三级专区第一集| 一区二区三区免费毛片| 久久久久久久久中文| 精品一区二区免费观看| 最近的中文字幕免费完整| 网址你懂的国产日韩在线| 国产男人的电影天堂91| 中文字幕亚洲精品专区| 午夜福利网站1000一区二区三区| 日本爱情动作片www.在线观看| 国产成人精品一,二区| 亚洲精品日韩av片在线观看| av卡一久久| 97超碰精品成人国产| 高清日韩中文字幕在线| 国产精品一二三区在线看| 高清午夜精品一区二区三区| 欧美日韩视频高清一区二区三区二| 真实男女啪啪啪动态图| 亚洲欧美精品专区久久| 婷婷色综合www| 伦精品一区二区三区| 国产男人的电影天堂91| 如何舔出高潮| 久久久久久九九精品二区国产| 天美传媒精品一区二区| av在线老鸭窝| 街头女战士在线观看网站| 2021少妇久久久久久久久久久| 国产精品99久久久久久久久| 国产一区亚洲一区在线观看| 国产69精品久久久久777片| av.在线天堂| 国产黄片视频在线免费观看| 啦啦啦韩国在线观看视频| 深夜a级毛片| 在线免费十八禁| www.av在线官网国产| 久久久久久国产a免费观看| 久久精品国产鲁丝片午夜精品| freevideosex欧美| 美女cb高潮喷水在线观看| 天天一区二区日本电影三级| 日韩伦理黄色片| 亚洲高清免费不卡视频| 在线播放无遮挡| 婷婷六月久久综合丁香| 亚洲精品成人av观看孕妇| a级一级毛片免费在线观看| 国产极品天堂在线| av国产久精品久网站免费入址| av线在线观看网站| 精品一区二区三区人妻视频| 国精品久久久久久国模美| 午夜视频国产福利| 高清日韩中文字幕在线| 免费看日本二区| 在线观看av片永久免费下载| 能在线免费看毛片的网站| 99re6热这里在线精品视频| 九色成人免费人妻av| 亚洲美女搞黄在线观看| av在线观看视频网站免费| 日本一二三区视频观看| 精品酒店卫生间| 99九九线精品视频在线观看视频| 欧美97在线视频| 久久鲁丝午夜福利片| 国产免费福利视频在线观看| 久久6这里有精品| 成年女人在线观看亚洲视频 | 国产女主播在线喷水免费视频网站 | 人人妻人人澡欧美一区二区| 男人和女人高潮做爰伦理| 免费少妇av软件| 亚洲欧洲国产日韩| 亚洲精品成人av观看孕妇| 欧美xxⅹ黑人| 美女内射精品一级片tv| 少妇的逼水好多| 亚洲18禁久久av| 欧美日韩亚洲高清精品| 午夜日本视频在线| 麻豆成人午夜福利视频| 熟女电影av网| 在线观看免费高清a一片| 色5月婷婷丁香| 国产成人精品婷婷| 国产大屁股一区二区在线视频| 国产一区二区在线观看日韩| a级毛色黄片| 天天躁夜夜躁狠狠久久av| 大香蕉97超碰在线| www.av在线官网国产| 青青草视频在线视频观看| 秋霞伦理黄片| 五月玫瑰六月丁香| 日本三级黄在线观看| 精品人妻视频免费看| a级毛色黄片| 久久久亚洲精品成人影院| 日韩亚洲欧美综合| 精品不卡国产一区二区三区| 丝袜美腿在线中文| 美女被艹到高潮喷水动态| 日韩制服骚丝袜av| 中文字幕亚洲精品专区| 亚洲自拍偷在线| 97精品久久久久久久久久精品| 亚洲国产高清在线一区二区三| 国产精品久久视频播放| 国产精品一区二区三区四区免费观看| av在线天堂中文字幕| 在线观看人妻少妇| 亚洲国产av新网站| 中文字幕制服av| av免费观看日本| 免费看av在线观看网站| 日日啪夜夜撸| 午夜激情欧美在线| 欧美日韩一区二区视频在线观看视频在线 | 亚洲欧美精品自产自拍| 美女内射精品一级片tv| 女人久久www免费人成看片| 久久99热这里只频精品6学生| 中文字幕久久专区| xxx大片免费视频| 国产精品麻豆人妻色哟哟久久 | 天堂影院成人在线观看| 少妇被粗大猛烈的视频| 99久国产av精品| 少妇人妻一区二区三区视频| 色视频www国产| 人人妻人人澡欧美一区二区| 日韩一区二区三区影片| 午夜福利在线在线| 秋霞在线观看毛片| 亚洲激情五月婷婷啪啪| 简卡轻食公司| ponron亚洲| 麻豆成人午夜福利视频| 国产免费福利视频在线观看| 日本一二三区视频观看| 日本免费在线观看一区| 春色校园在线视频观看| 一级毛片黄色毛片免费观看视频| 国语对白做爰xxxⅹ性视频网站| av福利片在线观看| 91久久精品国产一区二区成人| 国内精品一区二区在线观看| 日本爱情动作片www.在线观看| 熟妇人妻久久中文字幕3abv| 视频中文字幕在线观看| 欧美+日韩+精品| 欧美日韩视频高清一区二区三区二| 国产午夜精品论理片| 国产精品女同一区二区软件| 亚洲无线观看免费| 欧美性猛交╳xxx乱大交人| 国产伦理片在线播放av一区| 国产亚洲最大av| 国产在线男女| 久久久精品欧美日韩精品| 成人欧美大片| 有码 亚洲区| 亚洲人成网站在线观看播放| 一级毛片电影观看| 国产在线男女| 狂野欧美激情性xxxx在线观看| 国产日韩欧美在线精品| 国产成人精品婷婷| 美女被艹到高潮喷水动态| 国产精品三级大全| 99久久精品热视频| 亚洲不卡免费看| 99久久精品热视频| 天堂影院成人在线观看| 免费电影在线观看免费观看| 男女那种视频在线观看| 五月玫瑰六月丁香| 成年女人在线观看亚洲视频 | 听说在线观看完整版免费高清| 国产亚洲精品av在线| 久久综合国产亚洲精品| 精品少妇黑人巨大在线播放| 久久97久久精品| 日韩,欧美,国产一区二区三区| 欧美激情在线99| 久久这里有精品视频免费| 色综合亚洲欧美另类图片| 久久久久久久久久久丰满| 一本—道久久a久久精品蜜桃钙片 精品乱码久久久久久99久播 | 国产亚洲av嫩草精品影院| 寂寞人妻少妇视频99o| 人妻少妇偷人精品九色| 中文字幕av成人在线电影| 人妻系列 视频| 亚洲精品成人久久久久久| 欧美极品一区二区三区四区| 亚洲美女视频黄频| 老师上课跳d突然被开到最大视频| xxx大片免费视频| 国产激情偷乱视频一区二区| 亚洲av电影在线观看一区二区三区 | 极品少妇高潮喷水抽搐| 国产精品人妻久久久影院| 精品久久久久久久人妻蜜臀av| 一级二级三级毛片免费看| 国产伦精品一区二区三区四那| 搡老乐熟女国产| 亚洲精华国产精华液的使用体验| 一个人免费在线观看电影| 麻豆成人av视频| av卡一久久| 午夜福利在线观看免费完整高清在| 亚洲精品日本国产第一区| 亚洲精品乱码久久久久久按摩| 国产亚洲一区二区精品| 久久精品久久久久久噜噜老黄| 中文字幕人妻熟人妻熟丝袜美| 99久久中文字幕三级久久日本| 又黄又爽又刺激的免费视频.| 国产一区二区亚洲精品在线观看| 人妻一区二区av| 男女视频在线观看网站免费| 国产午夜福利久久久久久| 国产人妻一区二区三区在| 国产黄频视频在线观看| 午夜精品国产一区二区电影 | 只有这里有精品99| 久久久久久久国产电影| 日韩三级伦理在线观看| 午夜免费男女啪啪视频观看| 午夜亚洲福利在线播放| 伊人久久精品亚洲午夜| 插阴视频在线观看视频| 日韩一本色道免费dvd| 久热久热在线精品观看| 日本wwww免费看| 国产免费又黄又爽又色| 激情 狠狠 欧美| 国产白丝娇喘喷水9色精品| 亚洲最大成人手机在线| 午夜福利在线在线| 中文字幕免费在线视频6| 国产欧美另类精品又又久久亚洲欧美| 中文字幕av在线有码专区| 欧美zozozo另类|